HR 7970
Cleared committee
Adds a broad class of synthetic opioids called nitazenes to Schedule I of the Controlled Substances Act, making their scheduling permanent, and requires the Attorney General to issue implementing rules within one year.
Official title: STOP Nitazenes Act
Timeline each lane is a chamber; dates pull from congress.gov actions
House
Introduced
18-MAR-2026
Referred
18-MAR-2026
Approved by committee
21-JUL-2026
- Adds 2-benzylbenzimidazole opioids, known as nitazenes, to Schedule I, covering any material containing them or their salts and isomers.
- Defines the class by chemical structure and mu-opioid receptor agonist activity, and names eleven specific substances, including etonitazene and isotonitazene.
- Allows the Attorney General to publish by order in the Federal Register a list of substances that meet the definition.
- Makes substances previously under temporary scheduling permanent Schedule I substances as of the date of enactment.
- Requires an interim final rule within one year, followed by a final rule after a comment period and hearing opportunity.
No CRS summary yet. CRS writes one for most bills, often months after they move.
CRS is the Library of Congress's nonpartisan research office. Check on congress.gov- Judiciary Committee (House)
- Energy and Commerce Committee (House)
- Health Subcommittee
Crime and Law Enforcement
■ 9 R■ 1 D
9 Republicans
1 Democrat